Company Overview
ZSX Medical, LLC is a medical device company focused on improving surgical procedures and outcomes. ZSX Medical's device, Zip-Stitch™ will revolutionize surgical procedures in both the cesarean delivery and hysterectomy markets.
Cesarean surgery is the most prevalent large incision surgery in the world, and its prevalence is growing, both domestically and globally. This growth has been due to a number of factors, including the increasing age of first time mothers, the recognized dangers of vaginal birth after cesarean delivery (VBAC), the litigiousness of the obstetrics industry, and changing cultural attitudes surrounding childbirth. Cesarean deliveries represent the majority of births in China and much of Asia, as well as one third of all US births.
Hysterectomy is the second most prevalent large incision surgery in women’s health. Though almost half of hysterectomies are done by open surgery, the fastest-growing segment within this market is laparoscopic hysterectomy, driven by the financial and surgical imperatives targeted at decreasing invasiveness and minimizing hospitalization.
Sutures are the standard-of-care in for internal closure in both cesarean section and hysterectomy. However, they can cause tissue damage, act as a pathway for the spread of infection, demand technical skill, promote adhesions, and consume a huge fraction of the time spent in these procedures. Surgical staples and glues have taken market share from sutures in the cutaneous closure market, promising speed, and, in some cases, less tissue damage.
Like sutures, Zip-Stitch™ achieves hemostasis and wound closure, but unlike sutures, Zip-Stitch™ provides a physical barrier to adhesions and is not a conduit for infection. ZSX Medical is confident that these attributes and better patient outcomes will do much to break sutures’ monopoly in internal closure.
For more information regarding Zip-Stitch™, email us at info@zsxmedical.com.